Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Phytel

1996 FOUNDED
M&A STATUS
101-200 EMPLOYEES
M&A LATEST DEAL TYPE
$232M LATEST DEAL AMOUNT
Description

Provider of information technology services for physician communications and medical practice management. The company offers disease management and preventive care protocols that identify and notify non compliant patients of needed healthcare actions. It develops and maintains prescription, lab and clinical data for health and disease management. The company also offers systems integration, application development and reporting services.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Enterprise Systems (Healthcare)
Primary Office
  • 11511 Luna Road
  • Suite 600
  • Farmers Branch, TX 75234
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Phytel’s full profile, request a free trial.

Phytel Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 04-May-2015 $232M 000.00 00000 Completed Generating Revenue
7. Later Stage VC (Series G) 26-Aug-2013 000 000.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series F) 27-Aug-2012 00.00 000.00 000.00 Completed Generating Revenue
5. Later Stage VC (Series E) 11-Feb-2010 000.00 000.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series D) 29-Sep-2008 00.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 24-Dec-2007 000 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 07-Mar-2007 $3.35M $5.35M Completed Generating Revenue
1. Early Stage VC (Series A) 15-Apr-2005 $2M $2M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Phytel Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series G 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series F 000,000 00.000000 00 00 00 00 00 0.000
Series E 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series D 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 2,310,000 $0.001000 7% $1.45 $1.45 1x $1.45 11.56%
Series A 2,000,000 $0.001000 7% $1 $1 1x $1 10%
To view this company’s complete Cap Table, request access »

Phytel Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Caris Life Sciences PE-Backed Company Minority 000 0000 000000 0
Lah Investments Venture Capital Minority 000 0000 000000 0
Lord Rothschild Angel (individual) Minority 000 0000 000000 0
Polaris Partners Venture Capital Minority 000 0000 000000 0

Phytel Executive Team (18)

Name Title Board
Seat
Contact
Info
Steve Schelhammer Chief Executive Officer
Jeffrey Havlock Chief Financial Officer
Richard Hodach Chief Medical Officer
Jim Elder Senior Vice President, Sales and Client Services
Matt Waldron Senior Vice President, Strategic Corporate Development

3 Former Executives

You’re viewing 5 of 18 executives. Get the full list »